BVF INC/IL Diversified Active

Location: San Francisco, CA

CIK: 0001056807 · Show all filings

Period: Q3 2013 (← Previous) (Next →)

Filing Date: Nov 14, 2013

Total Value: $581M (89.4% shares, 10.6% debt)

Holdings (26)

LGND LIGAND PHARMACEUTICALS INC 23.5%

Value $136M Shares 3,153,665 Est. Cost — Unrealized —

IRWD IRONWOOD PHARMACEUTICALS INC 16.1%

Value $93.57M Shares 7,896,061 Est. Cost — Unrealized —

— ARRAY BIOPHARMA INC 10.4%

Value $60.46M Shares 9,719,589 Est. Cost — Unrealized —

— EXELIXIS INC 8.3%

Value $48.02M Shares 40,735,000 Est. Cost — Unrealized —

— RIGEL PHARMACEUTICALS INC 6.0%

Value $34.84M Shares 9,730,697 Est. Cost — Unrealized —

— TARGACEPT INC 5.6%

Value $32.77M Shares 6,171,669 Est. Cost — Unrealized —

— CHEMOCENTRYX INC 5.1%

Value $29.9M Shares 5,377,616 Est. Cost — Unrealized —

— ONCOTHYREON INC 3.1%

Value $18.28M Shares 8,872,778 Est. Cost — Unrealized —

EXEL EXELIXIS INC 2.5%

Value $14.56M Shares 2,502,256 Est. Cost — Unrealized —

— ARRAY BIOPHARMA INC 2.4%

Value $13.68M Shares 12,000,000 Est. Cost — Unrealized —

CYTK CYTOKINETICS INC 2.2%

Value $13.05M Shares 1,718,905 Est. Cost — Unrealized —

— REGADO BIOSCIENCES INC 1.9%

Value $11.1M Shares 1,659,091 Est. Cost — Unrealized —

— QLT INC 1.9%

Value $10.97M Shares 2,370,263 Est. Cost — Unrealized —

— AVANIR PHARMACEUTICALS INC 1.8%

Value $10.33M Shares 2,436,053 Est. Cost — Unrealized —

— RECEPTOS INC 1.4%

Value $8.31M Shares 320,000 Est. Cost — Unrealized —

— MIRATI THERAPEUTICS INC 1.4%

Value $8.262M Shares 545,372 Est. Cost — Unrealized —

— ARQULE INC 1.2%

Value $6.839M Shares 2,935,187 Est. Cost — Unrealized —

— PAIN THERAPEUTICS INC 1.1%

Value $6.412M Shares 2,357,327 Est. Cost — Unrealized —

— ONCOMED PHARMACEUTICALS INC 1.0%

Value $5.998M Shares 391,800 Est. Cost — Unrealized —

AGIO AGIOS PHARMACEUTICALS INC 0.9%

Value $5.508M Shares 196,996 Est. Cost — Unrealized —

— PALATIN TECHNOLOGIES INC 0.6%

Value $3.51M Shares 5,200,000 Est. Cost — Unrealized —

— SOPHIRIS BIO INC 0.5%

Value $2.808M Shares 600,000 Est. Cost — Unrealized —

— ANTHERA PHARMACEUTICALS INC 0.4%

Value $2.25M Shares 559,624 Est. Cost — Unrealized —

— REGULUS THERAPEUTICS INC 0.4%

Value $2.204M Shares 233,689 Est. Cost — Unrealized —

— GENVEC INC 0.1%

Value $617K Shares 486,100 Est. Cost — Unrealized —

— TRANSCEPT PHARMACEUTICALS INC 0.1%

Value $477K Shares 150,000 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
LGND	LIGAND PHARMACEUTICALS INC	3,153,665	$136M	23.5%	—	—	COM NEW	53220K504
IRWD	IRONWOOD PHARMACEUTICALS INC	7,896,061	$93.57M	16.1%	—	—	COM CL A	46333X108
—	ARRAY BIOPHARMA INC	9,719,589	$60.46M	10.4%	—	—	COM	04269X105
—	EXELIXIS INC	40,735,000	$48.02M	8.3%	—	—	NOTE 4.250% 08/15/2019	30161QAC8
—	RIGEL PHARMACEUTICALS INC	9,730,697	$34.84M	6.0%	—	—	COM NEW	766559603
—	TARGACEPT INC	6,171,669	$32.77M	5.6%	—	—	COM	87611R306
—	CHEMOCENTRYX INC	5,377,616	$29.9M	5.1%	—	—	COM	16383L106
—	ONCOTHYREON INC	8,872,778	$18.28M	3.1%	—	—	COM	682324108
EXEL	EXELIXIS INC	2,502,256	$14.56M	2.5%	—	—	COM	30161Q104
—	ARRAY BIOPHARMA INC	12,000,000	$13.68M	2.4%	—	—	NOTE 3.000% 06/01/2020	04269XAA3
CYTK	CYTOKINETICS INC	1,718,905	$13.05M	2.2%	—	—	COM NEW	23282W605
—	REGADO BIOSCIENCES INC	1,659,091	$11.1M	1.9%	—	—	COM	75874Q107
—	QLT INC	2,370,263	$10.97M	1.9%	—	—	COM	746927102
—	AVANIR PHARMACEUTICALS INC	2,436,053	$10.33M	1.8%	—	—	CL A NEW	05348P401
—	RECEPTOS INC	320,000	$8.31M	1.4%	—	—	COM	756207106
—	MIRATI THERAPEUTICS INC	545,372	$8.262M	1.4%	—	—	COM	60468T105
—	ARQULE INC	2,935,187	$6.839M	1.2%	—	—	COM	04269E107
—	PAIN THERAPEUTICS INC	2,357,327	$6.412M	1.1%	—	—	COM	69562K100
—	ONCOMED PHARMACEUTICALS INC	391,800	$5.998M	1.0%	—	—	COM	68234X102
AGIO	AGIOS PHARMACEUTICALS INC	196,996	$5.508M	0.9%	—	—	COM	00847X104
—	PALATIN TECHNOLOGIES INC	5,200,000	$3.51M	0.6%	—	—	COM PAR $ .01	696077403
—	SOPHIRIS BIO INC	600,000	$2.808M	0.5%	—	—	COM NEW	83578Q209
—	ANTHERA PHARMACEUTICALS INC	559,624	$2.25M	0.4%	—	—	COM NEW	03674U201
—	REGULUS THERAPEUTICS INC	233,689	$2.204M	0.4%	—	—	COM	75915K101
—	GENVEC INC	486,100	$617K	0.1%	—	—	COM NEW	37246C307
—	TRANSCEPT PHARMACEUTICALS INC	150,000	$477K	0.1%	—	—	COM	89354M106